[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359995-105":59,"doc-detail-359995-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","g3bp2-k76-acetylation-promotes-tumor-immunoescape-by-stabilizing-pd-l1-expression-in-colorectal-cancer","G3BP2-K76 acetylation promotes tumor immunoescape by stabilizing PD-L1 expression in colorectal cancer","","Acetylation-related mechanisms behind PD-L1 regulation in colorectal cancer remain insufficiently defined, despite limited responses of CRC to PD-1/PD-L1 blockade due to immune evasion. The study uses co-immunoprecipitation and RNA immunoprecipitation to map protein and protein–RNA interactions, with western blot and qPCR quantifying protein and mRNA levels. Immunocompetent mouse models and patient-derived CRC samples assess therapeutic relevance. Results identify G3BP2 lysine 76 acetylation as a driver of PD-L1–mediated immune escape. Targeting this modification suppresses PD-L1 and enhances anti-PD-L1 synergy, indicating a resistance-overcoming strategy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/g3bp2-k76-acetylation-promotes-tumor-immunoescape-by-stabilizing-pd-l1-expression-in-colorectal-cancer/359995/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/g3bp2-k76-acetylation-promotes-tumor-immunoescape-by-stabilizing-pd-l1-expression-in-colorectal-cancer/359995.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is colorectal cancer often resistant to PD-1/PD-L1 blockade immunotherapy?","Question",{"text":112,"@type":113},"CRC frequently evades immune surveillance through an immunosuppressive microenvironment, contributing to poor responses to PD-1/PD-L1 blockade. The mechanisms controlling PD-L1 expression are described as not fully understood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does G3BP2 acetylation at lysine 76 play in immune evasion?",{"text":117,"@type":113},"G3BP2 acetylation at K76 is identified as a key regulator of PD-L1-mediated immune evasion. It increases binding to PABPC1 and PD-L1 mRNA, stabilizing PD-L1 and raising its expression.",{"name":119,"@type":110,"acceptedAnswer":120},"How can K76 acetylation be targeted to improve treatment outcomes?",{"text":121,"@type":113},"A peptide inhibitor targeting K76 acetylation (K76-pe) effectively suppresses PD-L1 expression and synergizes with anti-PD-L1 therapy in vivo. This supports targeting the G3BP2-K76 acetylation pathway as a strategy to overcome immunotherapy resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359995,1790209070,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Jie etal. Cell Communication and Signaling (2026) 24:284  \n[https://doi.org/10.1186/s12964-026-02804-4](https://doi.org/10.1186/s12964-026-02804-4)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nG3BP2-K76 acetylation promotes tumor immunoescape by stabilizing PD-L1 expression in colorectal cancer  \nHaiqing Jie1,2,3†, Xuanhua Yang1,2,3†, Yujie Hou1,2,3†, Wenfeng Liang1,2,3, Wenxin Li 1,2,3, Ze Li1,2,3, Dongxu Lei 1,2,3, Hao Xie1,2,3, Tanxing Cai1,2,3, Zhiping Chen1,2,3, Yang Li4*†, Huashan Liu1,2,3*† and Liang Kang1,2,3*†  \nAbstract  \nBackground Colorectal cancer (CRC) often evades immune surveillance, leading to poor responses to PD-1/ PD-L1 blockade immunotherapy. The underlying mechanisms regulating PD-L1 expression remain incompletely understood.  \nMethods We utilized co-immunoprecipitation (Co-IP) and RNA immunoprecipitation (RIP) to investigate proteinprotein and protein–RNA interactions. Western blot (WB) and quantitative PCR (qPCR) were applied to assess protein and mRNA expression levels, respectively. Immunocompetent mouse models and patient-derived CRC samples were used to evaluate clinical relevance and therapeutic targeting.  \nResults We identified acetylation of G3BP2 at lysine 76 (K76) as a key regulator of PD-L1-mediated immune evasion. This modification is catalyzed by p300 and reversed by HDAC6 . Acetylated G3BP2 enhances binding to PABPC1 and PD-L1 mRNA, increasing its stability and upregulating PD-L1 expression. Consequently, tumors exhibit reduced cytotoxic T lymphocyte infiltration and acquire resistance to anti-PD-L1 therapy. Elevated G3BP2-K76 acetylation was observed in immunotherapy-resistant CRC tissues and promoted tumor growth in mice. A peptide inhibitor targeting K76 acetylation (K76-pe) effectively suppressed PD-L1 expression and synergized with anti-PD-L1 treatment in vivo. Conclusion G3BP2-K76 acetylation represents a critical post-translational mechanism driving immune evasion in CRC. Targeting this pathway may provide a promising strategy to overcome resistance to immunotherapy.  \n\n| †Haiqing Jie, Xuanhua Yang and Yujie Hou contributed equally to this work. |\n| --- |\n| †Yang Li, Huashan Liu and Liang Kang contributed equally to this work. |\n\n*Correspondence:  \nYang Li [1028168734@qq.com](1028168734@qq.com)[ ](1028168734@qq.com)Huashan Liu [liuhshan@mail2.sysu.edu.cn](liuhshan@mail2.sysu.edu.cn)[ ](liuhshan@mail2.sysu.edu.cn)Liang Kang [kangl@mail.sysu.edu.cn](kangl@mail.sysu.edu.cn)  \nFull list of author information is available at the end of the article  \nIntroduction  \nColorectal cancer (CRC) is a major global health issue, with 1,926,118 new cases and 903,859 deaths reported annually [1]. Under normal circumstances, the adaptive immune system is capable of recognizing and eliminating nascent tumors [2, 3]. However, CRC encompasses a heterogeneous group of diseases, each characterized by distinct genetic alterations. CRC tumors are typically associated with a highly immunosuppressive microenvironment, which enables cancer cells to evade immune surveillance and facilitates tumor progression [4, 5]. Thus, understanding the mechanisms behind CRC  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regul","cbCaij3RkVGz1qFI","https://ap.wps.com/l/cbCaij3RkVGz1qFI","pdf",4586122,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Highlights\n# Keywords\n# Introduction","[{\"question\":\"Why is colorectal cancer often resistant to PD-1/PD-L1 blockade immunotherapy?\",\"answer\":\"CRC frequently evades immune surveillance through an immunosuppressive microenvironment, contributing to poor responses to PD-1/PD-L1 blockade. The mechanisms controlling PD-L1 expression are described as not fully understood.\"},{\"question\":\"What role does G3BP2 acetylation at lysine 76 play in immune evasion?\",\"answer\":\"G3BP2 acetylation at K76 is identified as a key regulator of PD-L1-mediated immune evasion. It increases binding to PABPC1 and PD-L1 mRNA, stabilizing PD-L1 and raising its expression.\"},{\"question\":\"How can K76 acetylation be targeted to improve treatment outcomes?\",\"answer\":\"A peptide inhibitor targeting K76 acetylation (K76-pe) effectively suppresses PD-L1 expression and synergizes with anti-PD-L1 therapy in vivo. This supports targeting the G3BP2-K76 acetylation pathway as a strategy to overcome immunotherapy resistance.\"}]","G3BP2-K76 acetylation promotes tumor immunoescape by stabilizing PD-L1 expression in colorectal cancer | PDF",1790138434,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfcbcc45229152efcf38e1c3a815fa1d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c0538b3450f4c1c161eac341aca1377.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32baadf3b90d3d5b1cc976a4e29c5c5a.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ae1ea6139d48f6291de3a348b085c92.webp",980,1306]